Efficacy of electromagnetic therapy for urinary incontinence: A systematic review

被引:32
作者
Lim, Renly [1 ]
Lee, Shaun Wen Huey [2 ]
Tan, Ping Yee [2 ]
Liong, Men Long [3 ]
Yuen, Kah Hay [1 ]
机构
[1] Univ Sci Malaysia, Sch Pharmaceut Sci, George Town, Malaysia
[2] Monash Univ Malaysia, Sch Pharm, Bandar Sunway 46150, Selangor, Malaysia
[3] Isl Hosp, Dept Urol, Georgetown, Penang, Malaysia
关键词
device safety; magnetic stimulation; quality of life; urinary incontinence; EXTRACORPOREAL MAGNETIC INNERVATION; QUALITY-OF-LIFE; CONSERVATIVE TREATMENT; PELVIC FLOOR; ELECTRICAL-STIMULATION; URGE INCONTINENCE; CONTROLLED-TRIAL; SACRAL ROOTS; DOUBLE-BLIND; WOMEN;
D O I
10.1002/nau.22672
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims: To review whether patients with urinary incontinence (UI) treated with magnetic stimulation (MS) have a higher continence rate compared to sham. Methods: Computerized search of electronic databases was performed using the keywords magnetic stimulation therapy and urinary incontinence. Inclusion criteria were randomized, blinded and sham-controlled. Results: Eight studies involving 494 patients were included (285 patients received active MS and 209 patients received sham MS). Sample size ranged from 20 to 151 participants. Three studies were on stress UI, two studies on urgency UI, two studies on mixed UI and one study on overactive bladder. The primary outcome (cure) was not reported since only one study reported this outcome. Meta-analysis of the secondary outcome (improvement) showed patients who received active treatment were 2.3 times more likely to experience improved continence compared to sham treatment (95% confidence interval: 1.60-3.29; P<0.001), but was subject to bias due to varying inclusion criteria, poor reporting and variable time points. There were conflicting results in the treatment effect on quality of life (QOL). Twenty out of 494 patients (5%) experienced mild side effects. The longest follow up period was six months. Conclusions: There is no firm evidence to support the benefits of using MS in the management of UI, although short-term outcomes suggests that MS improves UI symptoms in women. The applicability of MS as a treatment option for UI remains uncertain until larger, high-quality trials with longer follow-up periods using comparable and relevant outcomes are conducted. Neurourol. Urodynam. 34:713-722, 2015. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:713 / 722
页数:10
相关论文
共 49 条
[1]   Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and Treatment of Urinary Incontinence, Pelvic Organ Prolapse, and Fecal Incontinence [J].
Abrams, P. ;
Andersson, K. E. ;
Birder, L. ;
Brubaker, L. ;
Cardozo, L. ;
Chapple, C. ;
Cottenden, A. ;
Davila, W. ;
de Ridder, D. ;
Dmochowski, R. ;
Drake, M. ;
DuBeau, C. ;
Fry, C. ;
Hanno, P. ;
Smith, J. Hay ;
Herschorn, S. ;
Hosker, G. ;
Kelleher, C. ;
Koelbl, H. ;
Khoury, S. ;
Madoff, R. ;
Milsom, I. ;
Moore, K. ;
Newman, D. ;
Nitti, V. ;
Norton, C. ;
Nygaard, I. ;
Payne, C. ;
Smith, A. ;
Staskin, D. ;
Tekgul, S. ;
Thuroff, J. ;
Tubaro, A. ;
Vodusek, D. ;
Wein, A. ;
Wyndaele, J. J. .
NEUROUROLOGY AND URODYNAMICS, 2010, 29 (01) :213-240
[2]   Urodynamic and clinical evaluation of 91 female patients with urinary incontinence treated with perineal magnetic stimulation: 1-year followup [J].
Almeida, FG ;
Bruschini, H ;
Srougi, M .
JOURNAL OF UROLOGY, 2004, 171 (04) :1571-1574
[3]   Hysterectomy and risk of stress-urinary-incontinence surgery: nationwide cohort study [J].
Altman, Daniel ;
Granath, Fredrik ;
Cnattingius, Sven ;
Falconer, Christian .
LANCET, 2007, 370 (9597) :1494-1499
[4]  
이중식, 2004, Investigative and Clinical Urology, V45, P438
[5]  
[Anonymous], INT UROGYNECOL J PEL
[6]  
[Anonymous], COCHRANE DATABASE SY
[7]  
[Anonymous], COCHRANE DATABASE SY
[8]  
[Anonymous], P INT CONT SOC ICS 3
[9]  
[Anonymous], NEUROUROL URODYN
[10]  
Bartoli S, 2010, UROLOGY, V75, P491, DOI 10.1016/j.urology.2009.07.1325